• 1. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Exclusive self-aligned β-phase PVDF films with abnormal piezoelectric coefficient prepared via phase inversion?
  N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Introduction to 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic Acid (CAS No. 849052-22-8)

3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound, identified by its CAS number 849052-22-8, is characterized by its unique structural features, which include both bromine and fluorine substituents, as well as a boronic acid moiety. These structural elements contribute to its versatility and make it a valuable intermediate in the synthesis of various bioactive molecules.

The presence of a boronic acid group in 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid enhances its reactivity, particularly in cross-coupling reactions such as the Suzuki-Miyaura coupling. This reaction is widely employed in the pharmaceutical industry for the construction of complex molecular architectures. The boronic acid functionality allows for the formation of carbon-carbon bonds, which are essential for creating intricate drug molecules with desired pharmacological properties.

The bromo substituent at the phenyl ring provides an additional handle for further functionalization, enabling chemists to introduce diverse chemical groups through palladium-catalyzed reactions. This flexibility is particularly useful in medicinal chemistry, where the optimization of drug candidates often requires iterative modifications.

The fluorine atom at the 4'-position of the benzyloxy group introduces electronic and steric effects that can influence the biological activity of the resulting compounds. Fluorinated aromatic compounds are well-documented for their ability to modulate metabolic stability, binding affinity, and other pharmacokinetic parameters. As a result, 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid serves as a promising building block for developing novel therapeutic agents.

In recent years, there has been a surge in research focused on boronic acids due to their role in targeted drug delivery systems and bioconjugation strategies. The ability of boronic acids to form stable complexes with biological molecules has opened up new avenues in therapeutic development. For instance, boron-containing compounds have shown promise in the treatment of various diseases, including cancer and inflammatory disorders.

One of the most notable applications of 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid is in the synthesis of boronate esters, which are known for their ability to interact with enzymes and receptors with high specificity. These interactions have been exploited in the development of kinase inhibitors and other small-molecule drugs. The bromo and fluorine substituents further enhance the potential of this compound by allowing for fine-tuning of its electronic properties and reactivity.

The pharmaceutical industry has increasingly recognized the importance of fluorinated compounds due to their favorable pharmacokinetic profiles. The introduction of fluorine atoms into drug molecules can lead to improved bioavailability, reduced metabolic clearance, and enhanced binding affinity. This has spurred significant interest in fluorinated intermediates like 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid, which can be readily incorporated into drug candidates during late-stage functionalization.

Advances in synthetic methodologies have also contributed to the growing utility of 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid. Modern techniques such as flow chemistry and microwave-assisted synthesis have enabled more efficient and scalable production of this compound. These innovations have made it more accessible for researchers to explore its potential in drug discovery and material science applications.

The role of 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid extends beyond pharmaceuticals into other areas such as polymer science and optoelectronics. The ability to incorporate boronic acid functionalities into polymers has led to the development of smart materials with responsive properties. These materials can be designed to exhibit changes in their physical or chemical behavior under specific stimuli, making them valuable for applications ranging from sensors to drug-eluting implants.

In conclusion, 3-Bromo-2-(4'-fluorobenzyloxy)phenylboronic acid (CAS No. 849052-22-8) is a versatile compound with significant potential in multiple scientific domains. Its unique structural features make it an invaluable intermediate for synthesizing complex molecules with tailored biological activities. As research continues to uncover new applications for boronic acids and fluorinated compounds, the importance of this compound is likely to grow even further.

• 779331-47-4(2-(Benzyloxy)-5-fluorophenylboronic Acid)
• 849052-23-9(3-Bromo-2-(4'-chlorobenzyloxy)phenylboronic acid)
• 849052-24-0(3-Bromo-2-(3'-methoxybenzyloxy)phenylboronic acid)
• 352534-84-0((3-Bromo-5-fluoro-2-isopropoxyphenyl)boronic acid)
• 352534-85-1(3-Bromo-2-butoxy-5-fluorophenylboronic acid)
• 849062-18-6(3-Bromo-2-(2'-fluorobenzyloxy)-5-methylphenylboronic acid)
• 849062-23-3(3-Bromo-5-methyl-2-(3'-methoxybenzyloxy)phenylboronic acid)
• 849052-16-0(3-Bromo-2-(3'-bromobenzyloxy)-5-methylphenylboronic acid)
• 352525-85-0(3-Bromo-5-fluoro-2-methoxyphenylboronic acid)
• 352534-82-8(3-Bromo-2-ethoxy-5-fluorophenylboronic acid)